
Clotloc 75 Tablet
Marketer
Hicxica Formulations Pvt Ltd
Salt Composition
Clopidogrel (75mg)
Overview Clotloc 75 Tablet
CardioGuard 75mg tablets are antiplatelet agents, preventing the formation of potentially harmful blood clots within the circulatory system. This significantly reduces the risk of stroke or myocardial infarction. A commonly prescribed cardioprotective medication, CardioGuard 75mg is indicated for patients at elevated risk of cardiovascular events. This includes individuals with peripheral artery disease (reduced blood flow due to vascular narrowing), those who have recently experienced a heart attack or stroke, those with arrhythmias, and post-stent placement. It's also employed adjunctively in the management of acute myocardial infarction and unstable angina. This medication can be ingested with or without food, consistently at the same time daily. Continuous use is crucial, even during periods of well-being, as discontinuation elevates the risk of cardiovascular complications. The most frequently reported adverse effect is bleeding, manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual flow. Wound healing may be prolonged. While typically mild and self-limiting, persistent or concerning bleeding necessitates immediate medical consultation. CardioGuard 75mg is contraindicated in individuals with active internal bleeding (e.g., gastric ulcer, intracranial hemorrhage). Prior to initiation, inform your physician of any existing bleeding disorders, recent major trauma, or upcoming surgery. Temporary cessation may be necessary before scheduled surgical or dental procedures.
Uses of Clotloc 75 Tablet
Reducing the risk of cardiovascular events
Major Benefits of Clotloc 75 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Clotloc 75 Tablet can be consumed with or without food; however, consistent timing is recommended for optimal results.
Common Side effects of Clotloc 75 Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Clotloc 75 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Clotloc 75 Tablet can be consumed with or without food, although consistent timing is recommended.
How Clotloc 75 Tablet works:
Aggrenox 75mg tablets inhibit platelet aggregation, thus reducing the risk of dangerous thrombus formation and subsequently lowering the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Use of Clotloc 75 Tablet with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Clotloc 75 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Seek medical advice before taking this medication.
Breast feedingSAFE IF PRESCRIBED
The medication Clotloc 75 Tablet is likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Clotloc 75 Tablet.
KidneySAFE IF PRESCRIBED
Clotloc 75 Tablets pose no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverSAFE IF PRESCRIBED
Clotloc 75 Tablet poses no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Clotloc 75 Tablet :
Should you forget a Clotloc 75 Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Clotloc 75 Tablet
| Label | Value |
|---|---|
| Chemical Type | Amino acid alkyl esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |
